Apotea AB (publ) (”Apotea”) will publish its Q3 2026 report at 07:30 am CEST on Thursday 5th of November. Investors, analysts, media and other interested parties are welcome to join a webcast and presentation of the interim report at 09:30 am the same day.
The results for the period January – September 2026 will be presented by Pär Svärdson, CEO, Sarah Ahnström, COO, and Johan Mårild, CFO via a webcast held on Thursday 5th of November 2026 at 09:30 am.
Link for webcast participation (no advance notification is necessary): https://events.inderes.com/apotea/q3-report-2026
If you wish to participate via teleconference, please register on the link below: https://events.inderes.com/apotea/q3-report-2026/dial-in
The presentation will be held in English.
For further information, please contact:
Stefan Eriksson, deputy CEO & Investor Relations
E-mail: ir@apotea.se
About Apotea
Apotea is Sweden’s leading online pharmacy with ambition to become the pharmacy of tomorrow by continuously simplifying and enhancing the customer experience. With the widest assortment on the market, low prices and fast deliveries, Apotea facilitates everyday life for over three million active customers. In E-barometern’s 2025 customer survey, Apotea was ranked as customers’ favourite e-commerce store for the eighth consecutive year. Since 2022, the group also operates in Norway through its Norwegian subsidiary Apotera.